1673-5269
2009 Issue 13
..............page:1045
Radiation therapy for hepatocellular carcinoma——current status and perspectives
ZENG Zhao-chong Department of Radiation Oncology;Zhongshan Hospital;Fudan University;Shanghai 200032;P.R.China
ZENG Zhao-chong Department of Radiation Oncology;Zhongshan Hospital;Fudan University;Shanghai 200032;P.R.China
..............page:961-965
Expression and clinical significance of transcription regulation factor DEC1 in gastric cancer tissues
WANG Min1;ZHENG Yan2;JIA Yan-fei2;LI Bin-bin2;WANG Yun-shan21.Institute of Basic Medical Sciences;Shandong Academy of Medical Sciences;Jinan 250062;P.R.China2.Central Laboratory;Jinan Central Hospital Affiliated to Shandong University;Jinan 250013;P.R.China
WANG Min1;ZHENG Yan2;JIA Yan-fei2;LI Bin-bin2;WANG Yun-shan21.Institute of Basic Medical Sciences;Shandong Academy of Medical Sciences;Jinan 250062;P.R.China2.Central Laboratory;Jinan Central Hospital Affiliated to Shandong University;Jinan 250013;P.R.China
..............page:1002-1005
Laparoscopic radio-frequency ablation in treatment of hepatic carcinoma
SONG Xi-lin1;SHI Xue-tao1;SONG Jin-long1;LI Yan-liang1;SU Qin2;LI Zeng-jun1;ZHANG Bo1;ZHOU Wu-yuan11.Shandong Tumor Hospital & Institute;Jinan 250117;P.R.China2.Kuerle Hospital of Xinjiang Agricultural Division No.2;Kuerle 841000;P.R.China
SONG Xi-lin1;SHI Xue-tao1;SONG Jin-long1;LI Yan-liang1;SU Qin2;LI Zeng-jun1;ZHANG Bo1;ZHOU Wu-yuan11.Shandong Tumor Hospital & Institute;Jinan 250117;P.R.China2.Kuerle Hospital of Xinjiang Agricultural Division No.2;Kuerle 841000;P.R.China
..............page:1025-1027
Correlation of Beclin1 and NF-κBp65 with tumorigenesis and development of primary human hepatocellular carcinoma
WANG Xiao-wei;KANG Kai-fu Department of Pathology;Southern Medical University Affiliated Hospital;First People’s Hospital of Shunde;Shunde 528300;P.R.China
WANG Xiao-wei;KANG Kai-fu Department of Pathology;Southern Medical University Affiliated Hospital;First People’s Hospital of Shunde;Shunde 528300;P.R.China
..............page:974-977
xi tuo xi dan kang zhi yan chi guo min fan ying yi li bao gao
fang ming zhi li min
fang ming zhi li min
..............page:1040
..............page:1046
Expression and clinical significance of Rhoc and Survivin mRNA in hepatocellular carcinoma
ZHU Wei;ZHANG Zhi-ming;WU Fei-xiang;LIU Jian-yong;YUAN Wei-ping;ZHAO Yin-nong Department of Hepatobiliary Surgery;Affiliated Tumor Hospital of Guangxi Medical University;Nanning 530021;P.R.China
ZHU Wei;ZHANG Zhi-ming;WU Fei-xiang;LIU Jian-yong;YUAN Wei-ping;ZHAO Yin-nong Department of Hepatobiliary Surgery;Affiliated Tumor Hospital of Guangxi Medical University;Nanning 530021;P.R.China
..............page:1009-1012
Comparing study of therapeutic effect for treating small cell carcinoma by nephron-sparing surgery and radical nephrectomy
LI Yong-sheng;ZHU Shao-xing;CHEN Shi-ping;XU En-ci;ZHENG Song;CAI Wei-zhong;WANG Bin;WENG Ming-gao;LU Qing Department of Urology;Union Hospital of Fujian Medical College;Fuzhou 350001;P.R.China
LI Yong-sheng;ZHU Shao-xing;CHEN Shi-ping;XU En-ci;ZHENG Song;CAI Wei-zhong;WANG Bin;WENG Ming-gao;LU Qing Department of Urology;Union Hospital of Fujian Medical College;Fuzhou 350001;P.R.China
..............page:1033-1035
Expression and significance of VEGF-C in human hepatocellular carcinoma tissnes
JIANG Ai-lian1;GUO Zi-bo2;DING Zhao-xi31.Department of Anatomy;Medical Colleage of Taishan Universiy;Taian 271000;P.R.China2.Jin’ao Chemical Industry Co.Ltd.Jinan 250100;P.R.China3.Department of Anatomy;Medical Colleage of Shandong Universiy;Jinan 250012;P.R.China
JIANG Ai-lian1;GUO Zi-bo2;DING Zhao-xi31.Department of Anatomy;Medical Colleage of Taishan Universiy;Taian 271000;P.R.China2.Jin’ao Chemical Industry Co.Ltd.Jinan 250100;P.R.China3.Department of Anatomy;Medical Colleage of Shandong Universiy;Jinan 250012;P.R.China
..............page:1006-1008
..............page:1041-1042
Clinical study of transcatheter arterial chemoembolization and hepatic perfusion with ~(131)I metuximad injection in treatment of hepatocellular carcinoma
WANG Gong-ping;FENG Xiao-shan;SHAN Tan-you;SUN Jiang-tao Department of Oncology;First Affiliated Hospital;Cancer Institute;Henan University of Science and Technology;Luoyang 471003;P.R.China
WANG Gong-ping;FENG Xiao-shan;SHAN Tan-you;SUN Jiang-tao Department of Oncology;First Affiliated Hospital;Cancer Institute;Henan University of Science and Technology;Luoyang 471003;P.R.China
..............page:1022-1024
Correlation between inhibition effect of gefitinib and epidermal growth factor receptorin nasopharyngeal carcinoma cells
PENG Pei-jian1;LIN Zhong1;LIAO Hai2;LI Su2;ZHANG Li21.Department of Chemo therapy;Fifth Affiliated Hospital of Sun Yat-sen University;Zhuhai 519000;P.R.China2.Department of Medical Oncology;Cancer Center of Sun Yat-sen University;Guangzhou;510060;P.R.China
PENG Pei-jian1;LIN Zhong1;LIAO Hai2;LI Su2;ZHANG Li21.Department of Chemo therapy;Fifth Affiliated Hospital of Sun Yat-sen University;Zhuhai 519000;P.R.China2.Department of Medical Oncology;Cancer Center of Sun Yat-sen University;Guangzhou;510060;P.R.China
..............page:978-981
Clinical features of 40 newly diagnosed type 2 diabetic ketosis patients with pancreatic cancer
SHI Ya-nan;ZHENG Li;WANG Shao-zhen Medical University Tianjin;Tianjin 300070;P.R.China
SHI Ya-nan;ZHENG Li;WANG Shao-zhen Medical University Tianjin;Tianjin 300070;P.R.China
..............page:1028-1030
..............page:1043
Complications of endoscopic submucosal dissection and management
ZHANG Rong;XU Guo-liang State Key Laboratory of Oncology in South China;Department of Endoscopy;Cancer Center;San Yat-sen University;Guangzhou 510060;P.R.China
ZHANG Rong;XU Guo-liang State Key Laboratory of Oncology in South China;Department of Endoscopy;Cancer Center;San Yat-sen University;Guangzhou 510060;P.R.China
..............page:1036-1039
2009 nian quan guo ru xian wei chuang shou shu xue xi ban zuo xue shu yan tao hui zheng wen tong zhi
..............page:1044
Clinical comparative study of PLF regimen and FOLFOX4 regimen on advanced gastric carcinoma
YAO Zhi-hua;LIU Yan-yan;ZHAO Yan;YANG Shu-jun;XU Lin-ping Department of Oncology;Tumor Hospital of Henan;Zhengzhou 450008;P.R.China
YAO Zhi-hua;LIU Yan-yan;ZHAO Yan;YANG Shu-jun;XU Lin-ping Department of Oncology;Tumor Hospital of Henan;Zhengzhou 450008;P.R.China
..............page:1019-1021,1024
..............page:1045
Effect of heme oxygenase on chemosensitivity of drug-resistant hepatic carcinoma Bel/Fu cell line
ZHANG Juan-kai;WANG Zhong-yu;DING Da-peng;XIN Yi Department of General Surgery;Affiliated Hospital;Dalian Medical University;Dalian 116044;P.R.China
ZHANG Juan-kai;WANG Zhong-yu;DING Da-peng;XIN Yi Department of General Surgery;Affiliated Hospital;Dalian Medical University;Dalian 116044;P.R.China
..............page:990-993
Correlation of expression of HIF-1α with MDR-related factors and chemosensitivity in gastric carcinoma tissues
WANG An-feng1;HAN Jie2;TAN Bi-bo2;GENG Wei2;LU·· Bing-rong2;SHI Wei-dong21.Department of Radiotherapy;Third Affiliated Hospital;Hebei Medical University;Shijiazhuang 050000;P.R.China2.Hebei Provincial Hospital;Shijiazhuang 050051;P.R.China
WANG An-feng1;HAN Jie2;TAN Bi-bo2;GENG Wei2;LU·· Bing-rong2;SHI Wei-dong21.Department of Radiotherapy;Third Affiliated Hospital;Hebei Medical University;Shijiazhuang 050000;P.R.China2.Hebei Provincial Hospital;Shijiazhuang 050051;P.R.China
..............page:998-1001
Retrospective analysis of diagnosis and surgical treatment for thyroid microcarcinoma
YAN Chao-qi1;YANG Wei-liang1;YANG Xue-wei1;WANG Shu-long2;YI Zheng-gui31.Department of General Surgery;Second Affiliated Hospital of Harbin Medical University;Harbin 150086;P.R.China2.Department of Surgery;People’s Hospital of Anda;Anda 152400;P.R.China3.Department of Surgery;Gongchangling Central Hospital of Liaoyang;Liaoyang 111000;P.R.China
YAN Chao-qi1;YANG Wei-liang1;YANG Xue-wei1;WANG Shu-long2;YI Zheng-gui31.Department of General Surgery;Second Affiliated Hospital of Harbin Medical University;Harbin 150086;P.R.China2.Department of Surgery;People’s Hospital of Anda;Anda 152400;P.R.China3.Department of Surgery;Gongchangling Central Hospital of Liaoyang;Liaoyang 111000;P.R.China
..............page:1016-1018
Effects of yiqijiedu mixture on tumor growth and expression of Ki-67 in transplanted human gastric carcinoma in nude mice
LU Jian-wei1;DAI Xiao-jun2;JI Jiang-hui1;LIU Shen-lin11.Nanjing University of Traditional Chinese Medicine;Nanjing 210046;P.R.China2.Yangzhou Hospital of Traditional Chinese Medicine;Yangzhou 225009;P.R.China
LU Jian-wei1;DAI Xiao-jun2;JI Jiang-hui1;LIU Shen-lin11.Nanjing University of Traditional Chinese Medicine;Nanjing 210046;P.R.China2.Yangzhou Hospital of Traditional Chinese Medicine;Yangzhou 225009;P.R.China
..............page:982-984
..............page:1044
Effect of systematic oropharyngeal management in prevention of acute radiation mucositis
JU Gui-fang;LU Ping-hua;WANG Wen-xia;JIAO Yu-hong Department Radiation Oncology;Shandong Tumor Hospital;Jinan 250117;P.R.China
JU Gui-fang;LU Ping-hua;WANG Wen-xia;JIAO Yu-hong Department Radiation Oncology;Shandong Tumor Hospital;Jinan 250117;P.R.China
..............page:1031-1032,1035
Retrospective analysis of patients with nasopharyngeal carcinoma treated by radiotherapy
ZHENG Zhi-jian;LIU Jian-hua;ZHANG Han-xiong;LUO Hai-ou;HUANG Guo-dong Department of Radiotherapy;Meizhou People’s Hospital;Meizhou 514031;P.R.China
ZHENG Zhi-jian;LIU Jian-hua;ZHANG Han-xiong;LUO Hai-ou;HUANG Guo-dong Department of Radiotherapy;Meizhou People’s Hospital;Meizhou 514031;P.R.China
..............page:1013-1015
Relationship between genetic polymorphisms of glutathione-s-transferase M1,T1 genes and susceptibility to hepatocellular carcinoma in population of Fusui District of Guangxi Zhuang Autonomous Region
YANG Zhi-guo;XIE Yu-an;KUANG Zhi-peng;LUO Xiao-ling;ZHANG Wei-ming;LENG Chao-hui Department of Experiment Study;Affiliated Tumor Hospital of Guangxi Medical University;Nanning 530021;P.R.China
YANG Zhi-guo;XIE Yu-an;KUANG Zhi-peng;LUO Xiao-ling;ZHANG Wei-ming;LENG Chao-hui Department of Experiment Study;Affiliated Tumor Hospital of Guangxi Medical University;Nanning 530021;P.R.China
..............page:970-973
..............page:1046
Mechanism of anti-cancer activities of cytokine induced killer cells in vitro
LI Fang-qiu;ZHANG Lei;LIU Qun;HUANG Hai-rong;LI De-min General Hospital of Nanjing Military Area Command;PLA;Nanjing 210002;P.R.China
LI Fang-qiu;ZHANG Lei;LIU Qun;HUANG Hai-rong;LI De-min General Hospital of Nanjing Military Area Command;PLA;Nanjing 210002;P.R.China
..............page:994-997
Anti-proliferation effect of oridonin on Nalm-6 cells and its mechanisms of action
LIU Jia-jun;ZHANG Jun-feng;LIN Dong-jun;LU Min-qiang Third Hospital of Sun Yat-sen University;Guangzhou 510630;P.R.China
LIU Jia-jun;ZHANG Jun-feng;LIN Dong-jun;LU Min-qiang Third Hospital of Sun Yat-sen University;Guangzhou 510630;P.R.China
..............page:966-969,989
Effects of HGF on expressions of VEGF-A,VEGF-C and VEGF-D of colon cancer cells SW480 and SW620
JIA Yi-tao1;LI Zhong-xin2;GUO Wei3;CAO Lei3;LI Yan3;ZHANG Lei31.Department of Oncology;Hebei General Hospital;Shijiazhuang 050051;P.R.China2.Department of Surgery Ⅱ;Fourth Hospital of Hebei Medical University;Shijiazhuang 050011;P.R.China 3.Department of Histology and Embryology;Hebei Medical University;Shijiazhuang 050011;P.R.China
JIA Yi-tao1;LI Zhong-xin2;GUO Wei3;CAO Lei3;LI Yan3;ZHANG Lei31.Department of Oncology;Hebei General Hospital;Shijiazhuang 050051;P.R.China2.Department of Surgery Ⅱ;Fourth Hospital of Hebei Medical University;Shijiazhuang 050011;P.R.China 3.Department of Histology and Embryology;Hebei Medical University;Shijiazhuang 050011;P.R.China
..............page:985-989